| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.27 | 0.09 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |